Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 3/20 | 0.55 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | EBP | Q15125 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5155798 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL29211112 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL8663800 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL29211136 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL10357746 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL8669195 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL8667621 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL12315579 | 1.00 | SCN5A (0.55) | SCN5ASCN9AGAASIGMAR1CES2 | |
| Hydrochloric Acid SCHEMBL7276407 | 0.98 | SCN5A (0.54) | SCN5ASCN9AGAASIGMAR1CES2 | |
| SCHEMBL1275973 | 0.98 | SCN5A (0.52) | SCN5ASCN9AGAASIGMAR1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207852-B1 | THERAPY FOR INCONTINENCE; CROHN'S DISEASE; MUSCLE RELAXANTS | BRIDGE PHARMA, INC. | 2001-03-27 | — | — | US | disclosed |